Unique ID issued by UMIN | UMIN000055121 |
---|---|
Receipt number | R000062970 |
Scientific Title | vildagliptin versus metformin on hepatic steatosis |
Date of disclosure of the study information | 2024/07/30 |
Last modified on | 2024/07/30 22:19:14 |
Vildagliptin versus metformin on hepatic steatosis in type 2 diabetic patients.
vildagliptin versus metformin on hepatic steatosis
vildagliptin versus metformin on hepatic steatosis
vildagliptin versus metformin on hepatic steatosis
Africa |
TYPE 2 DM
Medicine in general | Hepato-biliary-pancreatic medicine | Endocrinology and Metabolism |
Others
NO
Use of vildagliptin versus metformin on hepatic steatosis
Safety,Efficacy
Hepatic steatosis
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Vildagliptin
Metformin
40 | years-old | <= |
65 | years-old | >= |
Male and Female
T2DM
Severe disease
246
1st name | Asmaa |
Middle name | S. |
Last name | Mohamed |
Faculty of Pharmacy, Port Said University
Clinical Pharmacy and pharmacy practice Department
42526
Port said, Egypt.
01066953443
Asmaa.Mohamed@pharm.psu.edu.eg
1st name | Hosam |
Middle name | M. |
Last name | Ahmad |
Egypt Ministry of Health and population
Tropical and Biomedical Chemistry
61511
Minia, Egypt
01000638308
hosam.refaei1@gmail.com
Port said University
Self funding
Self funding
Faculty of Pharmacy, Port said University
Port said, Egypt
0663402344
Asmaa.Mohamed@pharm.psu.edu.eg
NO
2024 | Year | 07 | Month | 30 | Day |
Unpublished
Open public recruiting
2024 | Year | 01 | Month | 01 | Day |
2024 | Year | 01 | Month | 01 | Day |
2024 | Year | 01 | Month | 10 | Day |
2024 | Year | 06 | Month | 28 | Day |
2024 | Year | 07 | Month | 30 | Day |
2024 | Year | 07 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062970